The FDA will allow the use of purified CBD as an anti-seizure medication in about 50 patients treated at UCSF in San Francisco and the NYU School of Medicine in New York. The CBD will be provided by GW Pharmaceuticals, which has named its CBD product “Epidiolex”.
Cannabis has been used since biblical times as a treatment for epilepsy, which encompasses about 40 seizure disorders. The cannabis component “cannabidiol” has well-known anti-seizure properties, but its use has been banned up until recently due to the War on Pot. Tens of thousands have likely suffered and died as a result of the ban.
“If CBD turns out to be merely equal to conventional medications prescribed for epilepsy (rather than more effective), it may well be superior in terms of side effects. There is evidence that conventional anti-convulsants are detrimental to cognition and longterm development, whereas CBD is likely to prove benign.”